Literature DB >> 32424272

A rationally engineered cytosine base editor retains high on-target activity while reducing both DNA and RNA off-target effects.

Erwei Zuo1,2, Yidi Sun3,4, Tanglong Yuan5, Bingbing He6, Changyang Zhou6, Wenqin Ying6, Jing Liu5, Wu Wei4,7, Rong Zeng3,8, Yixue Li9,10,11,12, Hui Yang13,14.   

Abstract

Cytosine base editors (CBEs) offer a powerful tool for correcting point mutations, yet their DNA and RNA off-target activities have caused concerns in biomedical applications. We describe screens of 23 rationally engineered CBE variants, which reveal mutation residues in the predicted DNA-binding site can dramatically decrease the Cas9-independent off-target effects. Furthermore, we obtained a CBE variant-YE1-BE3-FNLS-that retains high on-target editing efficiency while causing extremely low off-target edits and bystander edits.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32424272     DOI: 10.1038/s41592-020-0832-x

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  1 in total

1.  Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1). structure-function relationships of RNA editing and dimerization.

Authors:  B B Teng; S Ochsner; Q Zhang; K V Soman; P P Lau; L Chan
Journal:  J Lipid Res       Date:  1999-04       Impact factor: 5.922

  1 in total
  26 in total

1.  Sequence-specific prediction of the efficiencies of adenine and cytosine base editors.

Authors:  Myungjae Song; Hui Kwon Kim; Sungtae Lee; Younggwang Kim; Sang-Yeon Seo; Jinman Park; Jae Woo Choi; Hyewon Jang; Jeong Hong Shin; Seonwoo Min; Zhejiu Quan; Ji Hun Kim; Hoon Chul Kang; Sungroh Yoon; Hyongbum Henry Kim
Journal:  Nat Biotechnol       Date:  2020-07-06       Impact factor: 54.908

2.  Programmable C-to-U RNA editing using the human APOBEC3A deaminase.

Authors:  Xinxin Huang; Junjun Lv; Yongqin Li; Shaoshuai Mao; Zhifang Li; Zhengyu Jing; Yidi Sun; Xiaoming Zhang; Shengxi Shen; Xinxin Wang; Minghui Di; Jianyang Ge; Xingxu Huang; Erwei Zuo; Tian Chi
Journal:  EMBO J       Date:  2020-10-15       Impact factor: 11.598

Review 3.  Improvement of base editors and prime editors advances precision genome engineering in plants.

Authors:  Kai Hua; Peijin Han; Jian-Kang Zhu
Journal:  Plant Physiol       Date:  2022-03-28       Impact factor: 8.340

Review 4.  CRISPR-derived genome editing therapies: Progress from bench to bedside.

Authors:  Holly A Rees; Alex C Minella; Cameron A Burnett; Alexis C Komor; Nicole M Gaudelli
Journal:  Mol Ther       Date:  2021-10-05       Impact factor: 11.454

5.  Detect-seq reveals out-of-protospacer editing and target-strand editing by cytosine base editors.

Authors:  Zhixin Lei; Haowei Meng; Zhicong Lv; Menghao Liu; Huanan Zhao; Hao Wu; Xiaoxue Zhang; Lulu Liu; Yuan Zhuang; Kailin Yin; Yongchang Yan; Chengqi Yi
Journal:  Nat Methods       Date:  2021-06-07       Impact factor: 28.547

Review 6.  Genetic therapies for the first molecular disease.

Authors:  Phillip A Doerfler; Akshay Sharma; Jerlym S Porter; Yan Zheng; John F Tisdale; Mitchell J Weiss
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

7.  Eliminating base-editor-induced genome-wide and transcriptome-wide off-target mutations.

Authors:  Lijie Wang; Wei Xue; Hongxia Zhang; Runze Gao; Houyuan Qiu; Jia Wei; Lina Zhou; Yun-Ni Lei; Xiaocheng Wu; Xiao Li; Chengfang Liu; Jing Wu; Qiubing Chen; Hanhui Ma; Xingxu Huang; Cheguo Cai; Ying Zhang; Bei Yang; Hao Yin; Li Yang; Jia Chen
Journal:  Nat Cell Biol       Date:  2021-05-10       Impact factor: 28.824

Review 8.  Gene-based therapies for neurodegenerative diseases.

Authors:  Jichao Sun; Subhojit Roy
Journal:  Nat Neurosci       Date:  2021-02-01       Impact factor: 24.884

9.  Efficient and high-fidelity base editor with expanded PAM compatibility for cytidine dinucleotide.

Authors:  Zhiquan Liu; Siyu Chen; Yingqi Jia; Huanhuan Shan; Mao Chen; Yuning Song; Liangxue Lai; Zhanjun Li
Journal:  Sci China Life Sci       Date:  2021-01-06       Impact factor: 6.038

10.  Precision genome editing using cytosine and adenine base editors in mammalian cells.

Authors:  Tony P Huang; Gregory A Newby; David R Liu
Journal:  Nat Protoc       Date:  2021-01-18       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.